News
New hepatitis medicines ‘pay for themselves’
A report into the value that Australians receive from government-subsidised medicines has highlighted the need to address spiralling rates of liver disease by adding breakthrough hepatitis C medicines to the …
Heart Foundation Walking helps disadvantaged groups
Heart Foundation Walking has been hailed as a best practice example for positively impacting the health of Australia’s socioeconomically disadvantaged groups. The debate piece, published in the International Journal of …
Elmwood Pharmacy’s Annette Walkerden in major artwork
Annette Walkerden from Elmwood Pharmacy in Wodonga is one of 40 small business owners from across Australia to be immortalised in a major artwork by Australian artist, Jenny McCracken. The …
Fiona Robertson awarded Victorian Pharmacist Medal
Fiona Robertson, a community pharmacist at Swan Hill was presented with the Victorian Pharmacist Medal at the Victorian Pharmacists Dinner. Robertson works full time at the Marraboor Pharmacy where she …
Stakeholders welcome regulatory framework report
The Australian Self Medication Industry and Complementary Medicines Australia have welcomed the Stage Two Expert Panel report on the regulatory framework for medicines and medical devices. “ASMI supports the majority …
Heatwave: consumers told to stay hydrated and cool
With Sydney facing its hottest November day since 1982 and much of NSW in a heatwave, AMA (NSW) is reminding consumers to stay hydrated and keep cool. “Heatwaves like the …
Final Report of Review of Medicines and Medical Devices Regulation
The second, and final, report from the Independent Review of Medicines and Medical Devices Regulation has been released. It highlights the importance of cutting red tape for the rapidly expanding …
Australia needs ‘cultural shift’ on antibiotics: NPS
NPS MedicineWise has used Antibiotic Awareness Week (16-22 November) to call for a ‘cultural shift’ in the way antibiotics are used in Australia to combat the serious health issue of …
New antibiotic from MSD
MSD today announced that its new antibiotic has been registered by the Therapeutic Goods Administration for the treatment of common and problematic gram-negative pathogens.
Time allows Regulation Impact Statement on codeine: PSA
The Pharmaceutical Society of Australia has welcomed the deferral of a final decision on the possible rescheduling of codeine. PSA National President, Joe Demarte says that the extra time allowed …
Australia the ‘lucky country’ in antibiotic resistance
With high per capita antibiotics usage, a new study has warned Australia is the “lucky country” and must remain vigilant if it is to maintain current levels of low antibiotic …
Stakeholders gear up on real-time codeine monitoring
The deferment of a final decision on the upscheduling of codeine-containing OTCs is very good news, but stakeholders now need to get moving quickly on the proposed real-time monitoring system …